S&P 500   4,545.18 (-0.12%)
DOW   35,721.13 (+0.82%)
QQQ   386.11 (-0.95%)
AAPL   188.58 (-0.42%)
MSFT   376.85 (-0.53%)
META   323.52 (-2.61%)
GOOGL   132.15 (-2.10%)
AMZN   145.18 (-0.78%)
TSLA   239.92 (-1.73%)
NVDA   467.16 (-2.96%)
NIO   7.21 (+0.42%)
BABA   74.31 (-0.48%)
AMD   120.20 (-2.95%)
T   16.47 (+1.04%)
F   10.32 (-2.55%)
MU   75.93 (-0.99%)
CGC   0.55 (-1.72%)
GE   120.60 (+1.46%)
DIS   92.62 (+0.13%)
AMC   6.85 (-4.46%)
PFE   30.43 (+1.16%)
PYPL   57.32 (-1.12%)
XOM   102.12 (-0.21%)
S&P 500   4,545.18 (-0.12%)
DOW   35,721.13 (+0.82%)
QQQ   386.11 (-0.95%)
AAPL   188.58 (-0.42%)
MSFT   376.85 (-0.53%)
META   323.52 (-2.61%)
GOOGL   132.15 (-2.10%)
AMZN   145.18 (-0.78%)
TSLA   239.92 (-1.73%)
NVDA   467.16 (-2.96%)
NIO   7.21 (+0.42%)
BABA   74.31 (-0.48%)
AMD   120.20 (-2.95%)
T   16.47 (+1.04%)
F   10.32 (-2.55%)
MU   75.93 (-0.99%)
CGC   0.55 (-1.72%)
GE   120.60 (+1.46%)
DIS   92.62 (+0.13%)
AMC   6.85 (-4.46%)
PFE   30.43 (+1.16%)
PYPL   57.32 (-1.12%)
XOM   102.12 (-0.21%)
S&P 500   4,545.18 (-0.12%)
DOW   35,721.13 (+0.82%)
QQQ   386.11 (-0.95%)
AAPL   188.58 (-0.42%)
MSFT   376.85 (-0.53%)
META   323.52 (-2.61%)
GOOGL   132.15 (-2.10%)
AMZN   145.18 (-0.78%)
TSLA   239.92 (-1.73%)
NVDA   467.16 (-2.96%)
NIO   7.21 (+0.42%)
BABA   74.31 (-0.48%)
AMD   120.20 (-2.95%)
T   16.47 (+1.04%)
F   10.32 (-2.55%)
MU   75.93 (-0.99%)
CGC   0.55 (-1.72%)
GE   120.60 (+1.46%)
DIS   92.62 (+0.13%)
AMC   6.85 (-4.46%)
PFE   30.43 (+1.16%)
PYPL   57.32 (-1.12%)
XOM   102.12 (-0.21%)
S&P 500   4,545.18 (-0.12%)
DOW   35,721.13 (+0.82%)
QQQ   386.11 (-0.95%)
AAPL   188.58 (-0.42%)
MSFT   376.85 (-0.53%)
META   323.52 (-2.61%)
GOOGL   132.15 (-2.10%)
AMZN   145.18 (-0.78%)
TSLA   239.92 (-1.73%)
NVDA   467.16 (-2.96%)
NIO   7.21 (+0.42%)
BABA   74.31 (-0.48%)
AMD   120.20 (-2.95%)
T   16.47 (+1.04%)
F   10.32 (-2.55%)
MU   75.93 (-0.99%)
CGC   0.55 (-1.72%)
GE   120.60 (+1.46%)
DIS   92.62 (+0.13%)
AMC   6.85 (-4.46%)
PFE   30.43 (+1.16%)
PYPL   57.32 (-1.12%)
XOM   102.12 (-0.21%)
Top-Rated StocksTop-Rated

IDEAYA Biosciences (IDYA) Insider Trading & Ownership

$31.93
+0.76 (+2.44%)
(As of 12:03 PM ET)
Compare
Today's Range
$31.66
▼
$33.24
50-Day Range
$24.59
▼
$32.00
52-Week Range
$13.29
▼
$33.24
Volume
395,702 shs
Average Volume
596,676 shs
Market Capitalization
$2.06 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.42
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability

IDEAYA Biosciences (NASDAQ:IDYA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$1.00 M
Get IDYA Insider Trade Alerts

Want to know when executives and insiders are buying or selling IDEAYA Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IDYA Insider Buying and Selling by Quarter


IDEAYA Biosciences Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/3/2023Jason ThroneinsiderSell5,163$30.09$155,354.67  
9/12/2023Jason ThroneinsiderSell1,000$30.00$30,000.00  
9/5/2023Jason ThroneinsiderSell1,737$30.03$52,162.11  
9/1/2023Jason ThroneinsiderSell2,100$30.03$63,063.00  
8/29/2023Paul A StoneCFOSell5,000$28.87$144,350.00  
8/21/2023Paul A StoneCFOSell978$26.40$25,819.20  
8/18/2023Paul A StoneCFOSell3,822$26.38$100,824.36  
8/16/2023Paul A StoneCFOSell200$26.43$5,286.00  
8/9/2023Jason ThroneinsiderSell5,000$25.09$125,450.00  
8/9/2023Paul A StoneCFOSell2,500$25.05$62,625.00  
7/10/2023Jason ThroneinsiderSell9,485$23.00$218,155.00  
5/31/2023Jason ThroneinsiderSell432$23.00$9,936.00  
5/22/2023Jason ThroneinsiderSell500$23.00$11,500.00  
(Data available from 1/1/2013 forward)












IDYA Insider Trading Activity - Frequently Asked Questions

Who is on IDEAYA Biosciences's Insider Roster?

The list of insiders at IDEAYA Biosciences includes Jason Throne, Mark Lackner, Michael P Dillon, and Paul A Stone. Learn more on insiders at IDYA.

What percentage of IDEAYA Biosciences stock is owned by insiders?

5.10% of IDEAYA Biosciences stock is owned by insiders. Learn more on IDYA's insider holdings.

Which IDEAYA Biosciences insiders have been selling company stock?

The following insiders have sold IDYA shares in the last 24 months: Jason Throne ($665,620.78), and Paul A Stone ($338,904.56).

How much insider selling is happening at IDEAYA Biosciences?

Insiders have sold a total of 37,917 IDEAYA Biosciences shares in the last 24 months for a total of $1,004,525.34 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:IDYA) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -